← Eichor
Study identifier: NCT07281794 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Condition: Parkinson Disease (PD) · Healthy (Controls)  ·  Sponsor: Northumbria University

PhaseN/A
Planned participants60
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

This observational study aims to explore the use of the DANU Smart Socks for gait and balance assessment in people with Parkinson's (PwP). The study will compare walking and balance outcomes produced by DANU from people with Parkinson's (PwP) and a group of healthy individuals of similar age. The project aims to investigate if the gait and balance data collected are linked to measures of Parkinson's symptoms such as disease progression and cognitive abilities. Gait and balance outcomes will be obtained through one observational laboratory visit.

This description comes directly from the study's public registry record.

Talk to the study team

Gabriella R Gatti, BSc  ·  01912273343  ·  gabriella.gatti@northumbria.ac.uk

Rodrigo Vitorio, PhD  ·  01912273343  ·  rodrigo.vitorio@northumbria.ac.uk

Always discuss trial participation with your own doctor first.

Locations (2)

Northumbria UniversityNewcastle upon Tyne, Tyne and Wear, United KingdomRecruiting
Northumbria UniversityNewcastle upon Tyne, United KingdomEnrolling By Invitation

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07281794